texas oncology more breakthroughs. more victories
Some of our cancer centers are experiencing issues.  View More Important Notifications x

Share:

 
 

Helen Dinkelspiel Eshed, M.D.

General Summary

Dr. Eshed is board-certified in obstetrics and gynecology as well as gynecologic oncology. She specializes in the diagnosis, treatment and management of women with gynecologic cancers including cervical, uterine or endometrial, ovarian, vulvar and vaginal cancers as well as gestational trophoblastic disease. Her special interests include research and clinical trials to improve patient outcomes and quality of life. She also educates providers in the community on the newest statistics and advancements in gynecologic oncology treatment and care.

Dr. Eshed provides specialized care while using the latest research and technology to create a comprehensive individualized treatment plan for each of her patients. She is a part of an expert care team at Texas Oncology, working together to help each patient from diagnosis and treatment to survivorship. Her focus for each patient is to provide the best possible care in a supportive, comfortable environment. She treats every patient the way she would treat her mother, sister or daughter. In addition to supporting her patients, Dr. Eshed also spends her personal time participating in charitable cancer related organizations like the Flatwater Foundation and Wonders and Worries. Both organizations not only support the patient, but the family members of the patient, another crucial aspect to the type of care Dr. Eshed provides at Texas Oncology.

Education

  • Fellowship in Gynecologic Oncology
    Columbia University College of Physicians and Surgeons, Weill Cornell Medical College, New York, NY
  • Residency in Obstetrics and Gynecology
    University of California Davis, Sacramento, CA
  • Medical Doctorate
    Albany Medical College, Albany, NY
  • Bachelor of Arts
    Dartmouth College, Hanover, NH

Stories of Inspiration

Accolades & Memberships

  • American Congress of Obstetrics and Gynecology
  • Austin’s Top Doctors, Gynecologic Oncology, Austin Monthly (2021)
  • Clinical Assistant Professor, Department of Women’s Health, Dell Medical School, The University of Texas at Austin
  • Conquer Cancer Foundation of American Society of Clinical Oncology (ASCO) Young Investigator Award grant recipient, 2015
  • Flatwater Foundation board member (2020 – present)
  • Society of Gynecologic Oncology
  • Super Doctors Texas Rising Stars, 2016-2018
  • Texas Oncology Austin Executive Committee member (2020 – present)
  • Texas Oncology Austin Marketing Committee member (2017 – present)
  • Women’s Health & Perinatal Professional Practice Committee member, 2020-present
  • Wonders & Worries Board Member

Surgery Locations

  • Ascension Seton Medical Center Austin
  • Dell Seton Medical Center at the University of Texas
  • St. David's Medical Center
  • St. David's South Austin Medical Center

Research Interest

Dr. Eshed is actively involved in clinical trials to individualize patient care and improve patients’ outcomes and quality of life. She has authored over a dozen peer-reviewed publications and presents lectures nationally and internationally on research in gynecologic cancers. She was the recipient of the American Society of Clinical Oncology (ASCO) Young Investigator Award grant for her research efforts in minimally invasive gynecologic cancer surgery.

Dr. Eshed is the principal investigator in USOR 17052 using an anti-PD1 monoclonal antibody REGN2810 vs. investigator’s choice chemotherapy for metastatic or recurrent platinum resistant cervical cancer.

Other Information

Originally from Tennessee, Dr. Eshed’s love for travel permeated her experiences in university and training. Dr. Eshed attended Dartmouth College in New Hampshire before going on to medical school at Albany Medical College in New York. She then finished her residency at the University of California Davis. After completing her fellowship training in Gynecologic Oncology at Columbia University and Weill Cornell Medical College in New York, NY she came to Austin, Texas to start her career and her family.

In addition to her clinical, academic, and research pursuits, Dr. Eshed stays active and has a passion for competitive racing including Ironman, marathons, and triathlons, having competed in the Boston Marathon, USAT Olympic National Championships, Ironman 70.3 World Championships, Ironman Couer d’Alene, and Ironman Mont Tremblant.

Dr. Eshed also enjoys spending time with her family including her husband, daughter, son and dog. She loves the outdoors, specifically skiing and hiking. In addition to her love for traveling, she is also passionate about music, making Austin the perfect city to live and raise her family.

Quotes from Online Portal

“Dr. Eshed is outstanding. She was recommended by my GYN and I have been a patient over 2 years now. She takes the time to answer all questions and is extremely knowledgeable. No question is too small. She is patient and understanding. In my experience, she’s not rushed to surgeries or extreme measures and looks at all factors while listening and understanding any concerns. She, and all of her staff, are fantastic and I’d definitely recommend.”

“Dr. Eshed is a wonderful, dedicated and gifted doctor. I am so blessed to have her as my oncologist. It is because of her that I am still alive today, and that is not an exaggeration. My children and grandchildren are the most precious thigs to me and I would not hesitate to call on her if in need.”

“Dr. Eshed is extremely knowledgeable and I trust her opinion and decisions implicitly. But most of all she is so compassionate and patient. Dr. Eshed listens not only with her ears but with her heart.”

“Dr. Eshed has been treating me for ovarian cancer for the past three years. I cannot praise her enough for her knowledge, and loving caring bedside manner.”

Publications

  • Feasibility and Learning Curve of Robotic Laparoendoscopic Single-Site Surgery in Gynecology

    Journal of Minimally Invasive Gynecology, 2017

  • A Case of Mesothelioma Masquerading Pre-Operatively As Ovarian Cancer and Brief Review of the Literature

    Gynecologic Oncology Reports, 2016

  • Does the Presence of Endometriosis Affect Prognosis in Ovarian Cancer?

    Cancer Invest, 2016

  • Sclerosing Mesenteritis Mimics Gynecologic Malignancy

    Gynecologic Oncology Reports, 2015

  • Long-Term Mortality Among Women With Epithelial Ovarian Cancer

    Gynecologic Oncology, 2015

Show all Publications
  • Use and Duration of Chemotherapy and Its Impact on Survival in Early-Stage Ovarian Cancer

    Gynecologic Oncology, 2015

  • Increased Cervical Cancer Risk Associated With Screening at Longer Intervals

    Obstetrics & Gynecology, 2015

  • State of the Science: Cervical Cancer Screening in Transition

    Gynecologic Oncology, 2014

  • New Mexico HPV Pap Registry Steering Committee. Cervical Excisional Treatment of Young Women: A Population-Based Study

    Gynecologic Oncology, 2014

  • Minimally Invasive vs. Open Pancreaticoduodenectomy: Systematic Review and Meta-Analysis

    Journal of the American College of Surgeons, 2014

  • Intraperitoneal Chemotherapy and Ileostomies in Ovarian Cancer

    Ninth International Symposium on Regional Cancer Therapies, 2014

  • The Presence of Endometriosis Is Associated With Improved Survival in Epithelial Ovarian Cancer

    Poster Presentation at the Society for Gynecologic Oncology 45th Annual Meeting on Women’s Cancer, 2014

  • Use and Duration of Chemotherapy and Its Impact on Survival in Early-Stage Ovarian Cancer

    Poster Presentation at the Society for Gynecologic Oncology 45th Annual Meeting on Women’s Cancer, 2014

  • Long-Term Mortality Among Women With Epithelial Ovarian Cancer

    Poster Presentation at the New York Obstetrics Society Meeting, 2014

  • Use and Duration of Chemotherapy and Its Impact on Survival in Early-Stage Ovarian Cancer

    Poster presentation at the New York Obstetrics Society Meeting, 2013

  • Identification of Master Regulators of Platinum Resistance in Ovarian Cancer

    Oral Plenary Presentation at the Society for Gynecologic Oncology 44th Annual Meeting on Women’s Cancer, 2013

  • Fallopian Tube Origin of Ovarian Cancer: Salpingectomy in Benign Gynecologic Surgery

    Oral Presentation at Columbia University College of Physicians and Surgeons Grand Rounds, 2013

  • Cervical Cancer Rates After the Transition From Annual Pap to 3-Year HPV and Pap

    Journal of Lower Genital Tract Disease, 2013

  • Contemporary Clinical Management of Endometrial Cancer

    Obstetrics and Gynecology International, 2013

  • Fallopian Tube Removal: “Stic-ing” It to Ovarian Cancer: What Is the Utility of Prophylactic Tubal Removal?

    Current Oncology, 2013

  • Screening History Preceding a Diagnosis of Cervical Cancer in Women Age 65 and Older

    Gynecologic Oncology, 2012

  • Screening History Preceding and Long-Term Risk of Invasive Cervical Cancer Following Diagnosis of Adenocarcinoma In Situ in Routine Clinical Practice

    Poster Presentation at the Society for Gynecologic Oncology 43rd Annual Meeting on Women’s Cancer, 2012

  • Sustained Rise in the Diagnosis of Adenocarcinoma In Situ in Routine Clinical Practice

    Poster Presentation at the American Society of Colposcopists and Cervical Pathologists Biennial Scientific Meeting, 2012

  • Pap Negative HPV Positive Screening Results: Compliance With Follow-Up and Results of Follow-Up

    Featured Poster presentation at the Society for Gynecologic Oncology 42nd Annual Meeting on Women’s Cancer, 2011

  • Consequences of Lengthening Cervical Cancer Screening Intervals on Mammography Rates

    Poster Presentation at the Society for Gynecologic Oncology 42nd Annual Meeting on Women’s Cancer, Orlando, 2011

  • Lessons From Practice: Cervical Cancer Antecedents in the Cotesting Era

    Oral Presentation at the Western Association of Gynecologic Oncologists 40th Annual Meeting, 2011

  • Screening History Preceding a Diagnosis of Cervical Cancer in Women Age 65 and Older

    Oral presentation at Eurogin Conference, 2011

  • Risk of Invasive Cancer in Routine Clinical Practice Following a CIN2 or CIN2/3 Biopsy

    Oral presentation at Eurogin Conference, 2011

  • Cervical Cancer Rates in Clinical Practice With Cotesting and Interval Extension

    Oral Plenary presentation at the Society for Gynecologic Oncology 42nd Annual Meeting on Women’s Cancer, 2011

Conditions

Dr. Dinkelspiel Eshed specializes in the care of women with gynecologic cancers including cervical, uterine or endometrial, ovarian, vulvar, vaginal cancers, gestational trophoblastic disease.

Procedures

Dr. Eshed has extensive experience in minimally invasive surgery including laparoscopic and da Vinci robotic surgery, complex pelvic surgery, and radical surgery for advanced cancers, as well as chemotherapeutic and novel treatments for gynecologic cancers.